| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Articles |
Cyclo-oxygenase is the rate-limiting enzyme in the prostanoid pathway. Although expression of the inducible isoform of cyclo-oxygenase (COX-2) is associated with cytokine-mediated inflammation, recent evidence suggests a homeostatic role for epithelial COX-2 in the gastrointestinal tract. The aim of this study was to examine the expression and localization of COX-2 in human airway epithelium both in vivo and in vitro. Human airway specimens from patients undergoing lung resection surgery for primary lung tumours (n=10) or nasal mucosal resection for non-inflammatory nasal obstruction (n=5) were examined for COX-2 expression by in situ hybridization and immunohistochemistry. COX-2 expression was also studied in two human airway epithelial cell lines (BEAS-2B and A549) using reverse transcription polymerase chain reaction and Northern and Western blot analysis. COX-2 messenger ribonucleic acid (mRNA) and protein were localized to individual columnar epithelial cells and to airway resident inflammatory cells in 9/10 lower and 5/5 upper airway specimens. Expression of COX-2 did not correlate with evidence of airway inflammation. Focal expression of COX-2 mRNA and protein was observed in bronchus-associated lymphoid tissue. Both COX-2 mRNA and protein were detected in BEAS-2B and A549 cells cultured under standard conditions. In conclusion, expression of COX-2 in human airway epithelium occurs in the upper and lower airways, is widespread in airway epithelial and airway resident inflammatory cells in the absence of overt airway inflammation, and is detectable in cultured human airway epithelial cells in the absence of inflammatory cytokine stimulation. These data suggest a potentially important homeostatic role for COX-2 in the regulation of human airway contractility, inflammation and immune responses.
This article has been cited by other articles:
|
|
 |
|
  L. Wang, V. Pozzato, G. Turato, A. Madamanchi, T. M. Murphy, and P. Chitano Reduced spontaneous relaxation in immature guinea pig airway smooth muscle is associated with increased prostanoid release Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L964 - L973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. T. Moreland, J. D. Procknow, R. S. Sprague, J. L. Iverson, A. J. Lonigro, and A. H. Stephenson Cyclooxygenase (COX)-1 and COX-2 Participate in 5,6-Epoxyeicosatrienoic Acid-Induced Contraction of Rabbit Intralobar Pulmonary Arteries J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 446 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-N. Wu, C.-W. Chen, S.-F. Liou, J.-L. Yeh, H.-H. Chung, and I.-J. Chen Inhibition of Proinflammatory Tumor Necrosis Factor-{alpha}-Induced Inducible Nitric-Oxide Synthase by Xanthine-Based 7-[2-[4-(2-Chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-Nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in Rat Trachea: The Involvement of Soluble Guanylate Cyclase and Protein Kinase G Mol. Pharmacol., September 1, 2006; 70(3): 977 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Balzary and T. M. Cocks Lipopolysaccharide Induces Epithelium- and Prostaglandin E2-Dependent Relaxation of Mouse Isolated Trachea through Activation of Cyclooxygenase (COX)-1 and COX-2 J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 806 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Baber, W. Deng, J. Rodriguez, R. G. Master, T. J. Bivalacqua, A. L. Hyman, and P. J. Kadowitz Vasoactive prostanoids are generated from arachidonic acid by COX-1 and COX-2 in the mouse Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1476 - H1487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shi, N. L. A. Misso, D. L. Duffy, B. Bradley, R. Beard, P. J. Thompson, and M-A. Kedda Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy Eur. Respir. J., August 1, 2005; 26(2): 249 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Baber, A. L. Hyman, and P. J. Kadowitz Role of COX-1 and -2 in prostanoid generation and modulation of angiotensin II responses Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2399 - H2410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Baber, H. C. Champion, T. J. Bivalacqua, A. L. Hyman, and P. J. Kadowitz Role of Cyclooxygenase-2 in the Generation of Vasoactive Prostanoids in the Rat Pulmonary and Systemic Vascular Beds Circulation, August 19, 2003; 108(7): 896 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Chin, C. N. Nagineni, L. C. Hooper, B. Detrick, and J. J. Hooks Cyclooxygenase-2 Gene Expression and Regulation in Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2338 - 2346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A E Redington, Q-H Meng, D R Springall, T J Evans, C Créminon, J Maclouf, S T Holgate, P H Howarth, and J M Polak Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment Thorax, May 1, 2001; 56(5): 351 - 357. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. A. Wollheim Selective Cox-2 inhibition in man--therapeutic breakthrough or cosmetic advance? Rheumatology, September 1, 2000; 39(9): 935 - 938. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
